Apogem Capital’s SpartanNash SPTN Stock Holding History

Apogem Capital’s Portfolio SPTN Stock Details SPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-35,197	Closed	-$1.16M	–	187
2022 Q1	$1.16M	Buy	+35,197	New	+$994K	0.79%	34

Other funds holding SPTN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Apogem Capital's SPTN Position: Q2 2022 in Review

Apogem Capital sold out of SpartanNash (SPTN) in Q2 2022, closing a stake of 35,197 shares — an estimated $1.16M sold.

Apogem Capital first reported a position in SPTN in Q1 2022 and held it in 1 quarter. The position peaked at $1.16M in Q1 2022. 222 funds tracked by Wall St. Rank hold SPTN as of Q2 2022.

Apogem Capital reported no remaining SpartanNash position as of Q2 2022 after selling out during the quarter.
Apogem Capital sold 35,197 SpartanNash shares in Q2 2022, an estimated $1.16M.
Apogem Capital first reported a position in SpartanNash in Q1 2022 and held it in 1 quarter.
Apogem Capital's SpartanNash position peaked at $1.16M in Q1 2022.
222 funds tracked by Wall St. Rank held SpartanNash as of Q2 2022.

Based on Apogem Capital's 13F filing for Q2 2022, filed 15 Aug 2022.